Nicolas Léveillé

1.7k total citations
11 papers, 780 citations indexed

About

Nicolas Léveillé is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Nicolas Léveillé has authored 11 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Nicolas Léveillé's work include RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Nicolas Léveillé is often cited by papers focused on RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Nicolas Léveillé collaborates with scholars based in Netherlands, Portugal and United States. Nicolas Léveillé's co-authors include Carlos A. Melo, Reuven Agami, Wouter de Laat, Sónia A. Melo, Patrick J. Wijchers, Raghu Kalluri, Ran Elkon, Harmen J.G. van de Werken, Elzo de Wit and Joachim A.F. Oude Vrielink and has published in prestigious journals such as Nature Communications, Molecular Cell and Oncogene.

In The Last Decade

Nicolas Léveillé

11 papers receiving 776 citations

Peers

Nicolas Léveillé

MB

CR

ONCOL

GENET

IMMUN

John Lalith Charles Richard United States

Ali Özeş United States

Oskar Marín-Béjar Spain

Ben R Hawley United States

Brian J. Reon United States

Ashish Goyal Germany

Xiaoling Li China

Feng Miao China

Roberto Vendramin Belgium

Jovanna González Spain

John Lalith Charles Richard United States

Nicolas Léveillé

503 ×0.7

MB

282 ×0.6

CR

73 ×0.8

ONCOL

43 ×1.2

GENET

48 ×1.6

IMMUN

Citations per year, relative to Nicolas Léveillé Nicolas Léveillé (= 1×) peers John Lalith Charles Richard

Countries citing papers authored by Nicolas Léveillé

Since Specialization

Citations

This map shows the geographic impact of Nicolas Léveillé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Léveillé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Léveillé more than expected).

Fields of papers citing papers by Nicolas Léveillé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Léveillé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Léveillé. The network helps show where Nicolas Léveillé may publish in the future.

Co-authorship network of co-authors of Nicolas Léveillé

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Léveillé. A scholar is included among the top collaborators of Nicolas Léveillé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Léveillé. Nicolas Léveillé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Moreno, Leandro F., et al.. (2023). Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens. STAR Protocols. 4(4). 102588–102588. 1 indexed citations

2.

Neerven, Sanne M. van, Wouter L. Smit, Vaishali Kakkar, et al.. (2022). Intestinal Apc ‐inactivation induces HSP25 dependency. EMBO Molecular Medicine. 14(12). e16194–e16194. 4 indexed citations

3.

Adam, R., Sanne M. van Neerven, Cayetano Pleguezuelos‐Manzano, et al.. (2020). Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer development. Cancer Cell International. 20(1). 578–578. 9 indexed citations

4.

Vermeulen, Louis, et al.. (2020). Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer. Cancers. 12(12). 3843–3843. 43 indexed citations

5.

Léveillé, Nicolas & S. Rubina Baglio. (2019). Exosome-transferred lncRNAs at the core of cancer bone lesions. Critical Reviews in Oncology/Hematology. 139. 125–127. 18 indexed citations

6.

Melo, Carlos A., Nicolas Léveillé, Koos Rooijers, et al.. (2016). A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response. Oncogene. 35(33). 4399–4406. 22 indexed citations

7.

Léveillé, Nicolas, Carlos A. Melo, Koos Rooijers, et al.. (2015). Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nature Communications. 6(1). 6520–6520. 138 indexed citations

8.

Léveillé, Nicolas, Carlos A. Melo, & Reuven Agami. (2015). Enhancer-associated RNAs as therapeutic targets. Expert Opinion on Biological Therapy. 15(5). 723–734. 25 indexed citations

9.

Melo, Carlos A., Jarno Drost, Patrick J. Wijchers, et al.. (2012). eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription. Molecular Cell. 49(3). 524–535. 428 indexed citations

10.

Léveillé, Nicolas, Ran Elkon, Verónica Dávalos, et al.. (2011). Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nature Communications. 2(1). 513–513. 81 indexed citations

11.

Léveillé, Nicolas, Andréa Fournier, & Claude Labrie. (2009). Androgens down-regulate myosin light chain kinase in human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 114(3-5). 174–179. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact